Showing results (621-630 of 6,394) with videos related to

Sort By:
Pageof 640
European Journal of Nuclear Medicine and Molecular Imaging|December 6, 2006
Amifostine protects rat kidneys during peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotateEdgar J Rolleman, Flavio Forrer, Bert Bernard, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 1, 2006
Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitisAnna Hartmann, Karim Eid, Claudio Dora, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2004
Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT?Patrick Reinartz, Franz-Josef Wieres, Wolfram Schneider, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2004
Registration accuracy of 153Gd transmission images of the brainF Jacobs, M Koole, I Goethals, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2004
Fluorinated tracers for imaging cancer with positron emission tomographyOlivier Couturier, André Luxen, Jean-François Chatal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2004
Scatter and attenuation correction changes interpretation of gated myocardial perfusion imagingAllan Johansen, Peter Grupe, Annegrete Veje, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2004
186Re-HEDP for metastatic bone pain in breast cancer patientsMarnix G E H Lam, John M H de Klerk, Peter P van Rijk
European Journal of Nuclear Medicine and Molecular Imaging|December 23, 2004
In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticalsRaphaël Boisgard, Bertrand Kuhnast, Stefan Vonhoff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 4, 2005
In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PETOliver Langer, Martin Brunner, Markus Zeitlinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2005
The route of administration (oral vs intravenous) does not influence dose or outcome in Graves' disease and unifocal autonomyPeter Schneider, Johannes Biko, Heribert Hänscheid, et al.
Pageof 640